Health Care & Life Sciences » Pharmaceuticals | NanoCarrier Co. Ltd.

NanoCarrier Co. Ltd. | Mutual Funds

Mutual Funds that own NanoCarrier Co. Ltd.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
JPM Asset JPM The Japan Mother Fund
2,414,597
5.24%
2,414,597
0.66%
03/26/2018
Baillie Gifford Overseas Growth Fund - Japanese Smaller Cos.
1,227,600
2.66%
0
0.56%
04/30/2018
Baillie Gifford Shin Nippon Plc
315,000
0.68%
0
0.25%
10/31/2017
Siemens Global Growth
106,300
0.23%
3,400
0.41%
04/30/2018
GO UCITS ETF Solutions Plc - Longer Dated All Commodities
44,900
0.1%
44,900
0.04%
02/28/2018
DIAM (Japan) Hybrid Selection Mother Fund
38,499
0.08%
25,499
0.18%
02/17/2017
SPDR S&P International Small Cap ETF
25,800
0.06%
0
0.01%
09/06/2018
CREF Stock Account
17,900
0.04%
0
0%
03/31/2018
Amundi (Japan) Resona Japan Growth Strategic Equity Open
14,938
0.03%
14,938
0.3%
04/25/2017
7,800
0.02%
0
0%
12/29/2017

About NanoCarrier Co.

View Profile
Address
144-15 Chuo
Kashiwa Chiba 277
Japan
Employees -
Website http://www.nanocarrier.co.jp
Updated 07/08/2019
NanoCarrier Co., Ltd. engages in the research, development, and production of pharmaceutical products through the use of micellar nanoparticles technology. These products are mainly used for cancer therapy. The company was founded by Kazunori Kataoka, Teruo Okano, and Ichiro Nakatomi on June 14, 1996 and is headquartered in Kashiwa, Japan.